Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 High throughput screening industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Products and services trends
2.1.4 Technology trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 High Throughput Screening Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of drug targets for screening
3.2.1.2 Technological Advancements in HTS
3.2.1.3 Rise in overall funding and capital investments
3.2.1.4 Surging adoption of open innovation models in pharma and biotech companies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complexities in assay development process
3.2.2.2 High cost of HTS instruments
3.3 Growth potential analysis
3.3.1 By products and services
3.3.2 By technology
3.3.3 By application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Future market trends
3.7 Technology and innovation landscape
3.8 Cell-based assay – Topic overview
3.9 Patent analysis
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Strategy dashboard, 2022
Chapter 5 High Throughput Screening Market Size and Forecast, By Products and Services (USD Million)
5.1 Key trends, products and services
5.2 Consumables
5.3 Instruments
5.3.1 Liquid Handling Systems
5.3.2 Others
5.4 Software and Services
Chapter 6 High Throughput Screening Market Size and Forecast, By Technology (USD Million)
6.1 Key trends, technology
6.2 Cell-based Assays
6.2.1 2D Cell Culture
6.2.2 3D Cell Culture
6.2.2.1 Scaffold-based Technologies
6.2.2.2 Scaffold-free Technologies
6.2.3 Reporter based Assays
6.2.4 Perfusion Cell Culture
6.3 Lab-on-a-chip
6.4 Label-free Technology
6.5 Ultra High Throughput Screening
Chapter 7 High Throughput Screening Market Size and Forecast, By Application (USD Million)
7.1 Key trends, application
7.2 Drug Discovery
7.3 Biochemical Screening
7.4 Life Sciences Research
7.5 Others
Chapter 8 High Throughput Screening Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, end-use
8.2 Pharmaceutical and Biotechnology Firms
8.3 Academic and Research Institutes
8.4 Contract Research Organizations
Chapter 9 High Throughput Screening Market Size and Forecast, By Region (USD Million)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 The Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Turkey
9.6.5 Israel
9.6.6 Iran
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Merck KGaA
10.3 Danaher Corporation
10.4 Thermofisher Scientific Inc.
10.5 PerkinElmer Inc.
10.6 Tecan Group Ltd.
10.7 Axxam SpA
10.8 Bio-Rad Laboratories
10.9 Hamilton Company
10.10 Biotek Instruments Inc.
10.11 Aurora Biomed
10.12 Corning Incorporated
10.13 Eurofins Scientific
